Please login to the form below

Not currently logged in
Email:
Password:

RRD International hires Ulrich Thienel as CDMO

Company expands leadership team with former Takeda VP

RRD International, a specialised product development company, has appointed Dr Ulrich Thienel as its new chief development and medical officer (CDMO).

As CDMO, Thienel will provide scientific, development and management leadership to PDTs formed between RRD and its partners, as well as play a key role in developing strategies to expand RRD's business.

In addition, Thienel will be involved in the advancement of RRD's ClearPath Development subsidiary, which helps bring companies, products and investors together.

Prior to joining RRD, Thienel served as vice president of asset strategy at Takeda.

Scott Tarrant, president of RRD International, said: “Dr Thienel is an ideal match for RRD and its growth needs as we continue to increase the scale and scope of our product development programmes.

“In his previous role at Takeda, Dr Thienel oversaw a team of more than 300 staff and was responsible for a large portfolio of assets. This extensive therapeutic and management experience combined with his strategy-driven approach to development offers an invaluable asset to RRD and our partners.”

27th July 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics